Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen

<p><strong>Purpose</strong> To conduct meta-analyses of randomized trials of aromatase inhibitors (AIs) compared with tamoxifen either as initial monotherapy (cohort 1) or after 2 to 3 years of tamoxifen (cohort 2).</p> <p><strong>Materials and Methods</strong...

Full description

Bibliographic Details
Main Authors: Dowsett, M, Cuzick, J, Ingle, J, Coates, A, Forbes, J, Bliss, J, Buyse, M, Baum, M, Buzdar, A, Colleoni, M, Coombes, C, Snowdon, C, Gnant, M, Jakesz, R, Kaufmann, M, Boccardo, F, Godwin, J, Davies, C, Peto, R
Format: Journal article
Language:English
Published: American Society of Clinical Oncology 2009